Adenosine administration produces an antidepressant-like effect in mice: Evidence for the involvement of A1 and A2A receptors

Neuroscience Letters

Volumn 355, Issue 1-2, 2004, Pages 21-24

  Kaster, Manuella P ^a   Rosa, Angelo Oscar ^a   Rosso, Matheus M ^b   Goulart, Eduardo C ^b   Santos, Adair R S ^a   Rodrigues, Ana Lúcia S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

Author keywords

Adenosine; CHA; Depression; DPCPX; DPMA; Forced swimming test; Tail suspension test; ZM241385

Indexed keywords

1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 6 N [2 (3,5 DIMETHOXYPHENYL) 2 (2 METHYLPHENYL)ETHYL]ADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ANTIDEPRESSANT AGENT; CAFFEINE; CYCLOHEXYLADENOSINE; DRUG DERIVATIVE; N(6) CYCLOPENTYLADENOSINE; N(6)-CYCLOPENTYLADENOSINE; TRIAZINE DERIVATIVE; TRIAZOLE DERIVATIVE; XANTHINE DERIVATIVE;

ANIMAL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE MODEL; DRUG EFFECT; EXPERIMENTAL TEST; FEMALE; FORCED SWIMMING TEST; LOCOMOTION; MALE; MENTAL STRESS; METABOLISM; MOTOR ACTIVITY; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; TAIL SUSPENSION TEST;

EID: 0346023027     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.10.040     Document Type: Article

References (20)

1. Bai F., Li X., Clay M., Lindstrom T., Skolnick P. Intra- and interstrain differences in models of 'behavioral despair'. Pharmacol. Biochem. Behav. 70:2001;187-192.
2. 2A receptor function in platelets in patients with major depression. Eur. Neuropsychopharmacol. 11:2001;183-186.
3. Borsini F., Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology. 94:1988;147-161.
4. De Mendonça A., Sebastião A.M., Ribeiro J.A. Adenosine: does it have a neuroprotective role after all? Brain Res. Rev. 33:2000;258-274.
5. Eckeli A.L., Dach F., Rodrigues A.L.S. Acute treatments with GMP produce antidepressant-like effects in mice. NeuroReport. 11:2000;839-843.
6. 2A receptor knockout mice. Br. J. Pharmacol. 134:2001;68-77.
7. El Yacoubi M., Ledent C., Parmentier M., Costentin J., Vaugeois J. SCH 58261 and ZM241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional 'atypical' adenosine A(2A) receptor. Eur. J. Pharmacol. 401:2000;63-77.
8. Elgün S., Keskinege A., Kumbasar H. Dipeptidyl peptidase IV and adenosine deaminase activity decrease in depression. Psychoneuroendocrinology. 24:1999;823-832.
9. Fredholm B.B., Ijzerman A.P., Jacobson K.A., Klotz K., Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53:2001;527-552.
10. 2A receptors inhibit the N-methyl-D-aspartate component of excitatory synaptic currents in rat striatal neurons. Eur. J. Pharmacol. 451:2002;161-164.
11. Manji H.K., Quiroz J.A., Sporn J., Payne J.L., Denicoff K., Gray N.A., Zarate Z.A. Jr, Charney D.S. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol. Psychiatry. 53:2003;707-742.
12. Minor T.R., Winslow J.L., Chang W.C. Stress and adenosine: II. Adenosine analogs mimic the effect of inescapable shock on shuttle-escape performance in rats. Behav. Neurosci. 108:1994;265-276.
13. Phillis J.W. Potentiation of the action of adenosine on cerebral cortical neurones by the tricyclic antidepressants. Br. J. Pharmacol. 83:1984;567-575.
14. Phillis J.W., Wu P.H. The effect of various centrally active drugs on adenosine uptake by the central nervous system. Comp. Biochem. Physiol. 72C:1982;179-187.
15. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229:1977;327-336.
16. Ribeiro J.A., Sebastião A.M., de Mendonça A. Adenosine receptors in the nervous system: pathophysiological implications. Prog. Neurobiol. 68:2003;377-392.
17. Sawynok J., Reid A. Desipramine potentiates spinal antinociception by 5-hydroxytryptamine, morphine and adenosine. Pain. 50:1992;113-118.
18. Skolnick P. Antidepressants for the new millennium. Eur. J. Pharmacol. 375:1999;31-40.
19. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology. 85:1985;367-370.
20. Zahorodna A., Bijak M., Hess G. Differential effects of repeated imipramine on hippocampal responsiveness to adenosine and serotonin. Eur. Neuropsychopharmacol. 12:2002;355-360.